Implication of prior treatment with drug combinations including inhibitors of topoisomerase II in therapy-related monocytic leukemia with a 9;11 translocation. [electronic resource]
Producer: 19910308Description: 53-8 p. digitalISSN:- 1045-2257
- Alkylating Agents -- adverse effects
- Antibiotics, Antineoplastic -- adverse effects
- Antineoplastic Combined Chemotherapy Protocols -- adverse effects
- Breast Neoplasms -- complications
- Chromosomes, Human, Pair 11 -- ultrastructure
- Chromosomes, Human, Pair 9 -- ultrastructure
- Cisplatin -- adverse effects
- Combined Modality Therapy
- Cyclophosphamide -- administration & dosage
- Dactinomycin -- adverse effects
- Doxorubicin -- administration & dosage
- Humans
- Iatrogenic Disease
- Leukemia, Monocytic, Acute -- chemically induced
- Mastectomy, Radical
- Middle Aged
- Podophyllotoxin -- adverse effects
- Radiotherapy
- Tamoxifen -- administration & dosage
- Topoisomerase II Inhibitors
- Translocation, Genetic
No physical items for this record
Publication Type: Case Reports; Journal Article; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, Non-P.H.S.; Research Support, U.S. Gov't, P.H.S.; Review
There are no comments on this title.
Log in to your account to post a comment.